Up to 40% of all epilepsy diagnoses in the United States are of the drug-resistant variety, affecting 1.2 million people ...

New techniques are increasingly effective, but we don't yet know how to combine different treatments in a tailored, ...

A Dutch neuromodulation developer has raised $60 million to complete the development of its minimally invasive implant for ...

NeuroPace announced preliminary one-year results from its clinical study evaluating neuromodulation therapy for generalized ...

Urinary and bowel disorders, manifesting as symptoms like frequent urination or difficulty in bowel movements, can greatly ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Maryam, a twelve-year-old from Yemen, suffered from a congenital spinal defect. She received treatment at Inamdar ...

A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.cvrx.com. About CVRx, Inc. CVRx is a commercial-stage medical ...

Salvia Bioelectronics BV raised $60 million in a series B financing round for its minimally invasive implantable neuromodulation device, Mysalvia therapy, which treats chronic migraine. The funds will ...

Salvia BioElectronics announced today that it completed a $60 million Series B financing round to support its migraine ...

Management of Tinnitus in Patients with and without Hearing Loss: A Systematic Review. International Journal of ...